Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and matrix metalloproteinase-2 in sacral chordomas

Oncology Letters

Volumn 3, Issue 6, 2012, Pages 1268-1274

  Li, Xiaoxiang ^a   Ji, Zhenwei ^a   Ma, Yunlei ^a   Qiu, Xiuchun ^a   Fan, Qingyu ^a   Ma, Baoan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chordoma; Hypoxia inducible factor 1 ; Matrix metalloproteinase 2; Vascular endothelial growth factor

Indexed keywords

GELATINASE A; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER PROGNOSIS; CANCER TISSUE; CHORDOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; SACRUM; SACRUM CHORDOMA; TISSUE MICROARRAY; TUMOR VASCULARIZATION;

EID: 84859448523     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.645     Document Type: Article

References (28)

1. McMaster ML, Goldstein AM, Bromley CM, Ishibe N and Parry DM: Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control 12: 1-11, 2001.
2. Anson KM, Byrne PO, Robertson ID, Gullan RW and Montgomery AC: Radical excision of sacrococcygeal tumours. Br J Surg 81: 460-461, 1994.
3. Tzortzidis F, Elahi F, Wright D, Natarajan SK and Sekhar LN: Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery 59: 230-237, 2006.
4. Chugh R, Tawbi H, Lucas DR, Biermann JS, Schuetze SM and Baker LH: Chordoma: the nonsarcoma primary bone tumor. Oncologist 12: 1344-1350, 2007.
5. Vaupel P, Hockel M and Mayer A: Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal 9: 1221-1235, 2007.
6. Majmundar AJ, Wong WJ and Simon MC: Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40: 294-309, 2010.
7. Huang LE, Gu J, Schau M and Bunn HF: Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95: 7987-7992, 1998.
8. Welsh SJ, Koh MY and Powis G: The hypoxic inducible stress response as a target for cancer drug discovery. Semin Oncol 33: 486-497, 2006.
9. Semenza GL: Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov Today 12: 853-859, 2007.
10. Dai Y, Bae K and Siemann DW: Impact of hypoxia on the metastatic potential of human prostate cancer cells. Int J Radiat Oncol Biol Phys 81: 521-528, 2011.
11. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD and Semenz GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613, 1996.
12. Shyu KG, Hsu FL, Wang MJ, Wang BW and Lin S: Hypoxia-inducible factor 1alpha regulates lung adenocarcinoma cell invasion. Exp Cell Res 313: 1181-1191, 2007.
13. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM and Johnson RS: Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 60: 4010-4015, 2000.
14. Kuwai T, Kitadai Y, Tanaka S, Elson D, Gassmann M, Arbeit JM and Johnson RS: Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 105: 176-181, 2003.
15. Kimura S, Kitadai Y, Tanaka S, Kuwai T, Hihara J, Yoshida K, Toge T and Chayama K: Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma. Eur J Cancer 40: 1904-1912, 2004.
16. Chaffer CL and Weinberg RA: A perspective on cancer cell metastasis. Science 331: 1559-1564, 2011.
17. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, Tsuneyama K and Takano Y: Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 26: 3579-3583, 2006.
18. Ji Z, Long H, Hu Y, Qiu X, Chen X, Li Z, Fan D, Ma B and Fan Q: Expression of MDR1, HIF-1alpha and MRP1 in sacral chordoma and chordoma cell line CM-319. J Exp Clin Cancer Res 29: 158, 2010.
19. Schweizer MS, Schumacher L and Rubin MA: Constructing tissue microarrays for research use. Curr Protoc Hum Genet Chapter 10: Unit 10.7, Feb. 2004.
20. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons JW: Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59: 5830-5835, 1999.
21. Xiang ZL, Zeng ZC, Fan J, Tang ZY, Zeng HY and Gao DM: Expression profiling of fixed tissues identified hypoxia-inducible factor-1 alpha, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma. Clin Cancer Res 17: 5463-5472, 2011.
22. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
23. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.
24. Rankin EB and Giaccia AJ: The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15: 678-685, 2008.
25. Bussolino F, Mantovani A and Persico G: Molecular mechanisms of blood vessel formation. Trends Biochem Sci 22: 251-256, 1997.
26. Chen KW, Yang HL, Lu J, Wang GL, Ji YM, Wu GZ, Zhu LF, Liu JY, Chen XQ and Gu YP: Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma. J Neurooncol 101: 357-363, 2011.
27. Naka T, Kuester D, Boltze C, Schulz TO, Samii A, Herold C, Ostertag H and Roessner A: Expression of matrix metallo-proteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma. Hum Pathol 39: 217-223, 2008.
28. Naka T, Boltze C, Kuester D, Schulz TO, Samii A, Herold C, Ostertag H and Roessner A: Expression of matrix metalloproteinase (MMP)-1, MMP-2, MMP-9, cathepsin B, and urokinase plasminogen activator in non-skull base chordoma. Am J Clin Pathol 122: 926-930, 2004.